Terumo EPS - Earnings per Share 2012-2024 | TRUMY

Terumo earnings per share (EPS) for the twelve months ending June 30, 2024 was $0.37, a 25.95% decline year-over-year.

  • Terumo EPS for the quarter ending June 30, 2024 was $0.15, a 13.1% decline year-over-year.
  • Terumo 2024 annual EPS was $0.49, a 12.05% increase from 2023.
  • Terumo 2023 annual EPS was $0.44, a 15.71% decline from 2022.
  • Terumo 2022 annual EPS was $0.52, a 8.75% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Terumo EPS - Earnings per Share 2012-2024 | TRUMY

  • Terumo EPS for the quarter ending June 30, 2024 was $0.15, a 13.1% decline year-over-year.
  • Terumo 2024 annual EPS was $0.49, a 12.05% increase from 2023.
  • Terumo 2023 annual EPS was $0.44, a 15.71% decline from 2022.
  • Terumo 2022 annual EPS was $0.52, a 8.75% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$200B
Stryker (SYK)$141B
Boston Scientific (BSX)$128B
Medtronic (MDT)$113B
EssilorLuxottica (ESLOY)$112.7B
Lonza Group Ag (LZAGY)$45.3B
Haleon (HLN)$43.5B
GE HealthCare Technologies (GEHC)$40.4B
ResMed (RMD)$36.5B
Koninklijke Philips (PHG)$25.9B
Zimmer Biomet Holdings (ZBH)$21.6B
Baxter (BAX)$18.4B
Insulet (PODD)$17.2B
Smith & Nephew SNATS (SNN)$10.8B
Bio-Rad Laboratories (BIO)$10.4B
BellRing Brands (BRBR)$8.9B
Demant (WILYY)$8.4B
Lantheus Holdings (LNTH)$6.1B
Haemonetics (HAE)$4.4B
ICU Medical (ICUI)$4.4B
TG Therapeutics (TGTX)$4.3B
Prestige Consumer Healthcare (PBH)$4B
Envista Holdings (NVST)$3.7B
Perrigo (PRGO)$3.7B
Neogen (NEOG)$3.4B
Agios Pharmaceuticals (AGIO)$3.1B
Shandong Weigao Medical Polymer (SHWGF)$3B
GN Store Nord (GNNDY)$2.9B
QuidelOrtho (QDEL)$2.6B
LeMaitre Vascular (LMAT)$2.3B